adrenomed-logo (002).jpg
AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock
10 avr. 2024 08h00 HE | Adrenomed AG
With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths...
DNA Methylation Market
DNA Methylation Market Analysis 2024-2032 by Product, Technology, Application, End User, and Region - Industry to Rise at a 13.9% CAGR
09 avr. 2024 11h43 HE | Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "DNA Methylation Market Report by Product, Technology, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Orphan Drug Sector Poised for Growth Amidst Unmet Rare Disease Needs
05 avr. 2024 04h04 HE | Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Global Orphan Drug Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study provides critical insights into the...
Biognosys’ DIA mass spectrometry unbiased proteomics platform.png
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
04 avr. 2024 08h11 HE | Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.
SHMNLogo.jpg
SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers
01 avr. 2024 09h30 HE | SOHM, Inc.
CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...
Global DNA Methylation Detection Technology Market
Global DNA Methylation Detection Technology Market Analysis 2023-2024 & 2023: Increasing Adoption as Epigenetic Biomarkers, Bisulfite Conversion as a Gold Standard, R&D in Genomics/Epigenetics
29 mars 2024 05h34 HE | Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Global DNA Methylation Detection Technology Market: Focus on Technology, Application, End User, Product Type, Country Level Analysis and Competitive...
Global Molecular Cytogenetics Market
Global Molecular Cytogenetics Market Forecast to Reach $3.39 Billion by 2029, Driven by Innovations in Oncology Diagnostics and Personalized Medicine
27 mars 2024 08h13 HE | Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
TeleDaas_Logo_Colour FINAL.png
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
25 mars 2024 08h02 HE | TeleDaas PLLC
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
Transfection Technologies Market
Transfection Technologies Market to Reach $1.8 Billion by 2028, Driven by Advances and Growing Demand for Therapeutic Delivery
22 mars 2024 05h05 HE | Research and Markets
Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "Global Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection,...
22157.jpg
Precision Medicine Market Deal Making Trends: "Precision Medicine Collaboration and Licensing Deals (2016-2023)" Comprehensive Report Released
18 mars 2024 05h39 HE | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. The realm of precision...